Antibodies against the CXC-ELR family of chemokines
US9605058B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 2013 |
| Grant date | Mar 28, 2017 |
| Priority date | — |
| Expiry date | May 1, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/41
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to antibodies which treat diseases in which human IL-8, Gro-alpha, Gro-beta, Gro-gamma, GCP-2, and/or ENA-78 are implicated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.